chrisvoncsefalvay/vaers-outcomes huggingface dataset:
1750 PATIENT COMPLAINS OF NAUSEA AND DIZZINESS. BP 165/71, HR 78, RR 18 1755 ATE SANDWICH, DRANK WATER, STATES SHE IS FEELING BETTER. NO OTHER COMPLAINTS 1820 STATES SHE IS BETTER. INSTRUCTED TO CALL EMS IF SYMPTOMS RETURN . PATIENT VERBALIZE UNDERSTANDING OF INSTRUCTIONS. DROVE SELF HOME
Immediately after receiving flu vaccine got headache and metallic taste in mouth. No further problem. Took Tylenol for headache.
Patient presented to the pharmacy 2 days after vaccine administration, complaining of redness, swelling and warmth on her left arm. Pt states she had pain after the vaccine but only for one day. However the redness and swelling were still present 2 days after vaccine administration. Pt also complains of itchiness in the area. Upon observation the area appeared red and swollen. Pt did not complain of any other symptoms. Pt was instructed to take Benadryl and go to her PCP so that she could be treated for the allergic reaction.
pt recvd phone call from MD to report a periostetial reaction lt femur; doing well now; seen by MD 28AUG92;
Pt was given a booster of Moderna at the age of 16.  No reaction was noted.  It was discovered after the vaccine was given that patient was under the recommended age for the Moderna Vaccine.
Suspected vaccination failure; still get shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The case was reported by the patient. The age at vaccination was not reported. The patient had the Shingles shot and still experienced shingles. The follow-up would not possible as no contact details were available. This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting.
This is a spontaneous report from a contactable consumer via a Pfizer sales representative. A patient of unspecified age and gender received PREVNAR 13 (lot number and expiration date unknown) via an unspecified route of administration on an unspecified date at a single dose for immunization. The patient's medical history and concomitant medications were not reported. The reporter described the first time pneumococcal 13-valent conjugated vaccine (diphtheria crm197 protein) was given. The patient experienced extreme swelling on an unspecified date.  The outcome of extreme swelling was unknown. No follow-up attempts are possible, information about batch number cannot be obtained.
Shingles; Vaccination failure; Information has been received regarding a case in litigation, referring to a female pt of unknown age. Information regarding the pt's pertinent medical history, concurrent conditions, known allergies and concomitant medications was not provided.     In 2015, the pt was vaccinated with zoster vaccine live (ZOSTAVAX) (route of administration, strength, dose, lot # and expiration date were not provided) for the long-term prevention of shingles and/or zoster-related conditions.         On an unknown date, the pt experienced shingles (herpes zoster). The pt healthcare provided, believed that it was effective in preventing shingles on a long-term or permanent basis that it did not carry any significant risks of adverse effects (vaccination failure). Pt was treated at a physician office an hospitalized on an unspecified date.   As a direct and proximate result of the pt's use of the zoster vaccine live (ZOSTAVAX) vaccine, had and would continued to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, included but not limited to medical losses and costs which included care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and will continue to suffer such losses, and damages in the future.         At the time of the report, the outcome of herpes zoster was reported as not recovered. The outcome of vaccination failure was unknown. The lawyer considered herpes zoster and vaccination failure to be related to zoster vaccine live (ZOSTAVAX).
6PM while conducting chorus pt exp forgetfulness & some confusion; pt didn't recognize familiar songs & had trouble recalling introduction & words to songs when conversing often lost train of thought; sx resolved by next AM;
anxiety at time of shot, then was on the phone while waiting then came over after about 10min and said was having palpitations, and was nervous. his bp was high and he was concerned so we had him call a ride as he didn't  feel he needed an ambulance but wanted to get check out. He went to urgent care and they told him it was anxiety and the my bp machine wasn't big enough for his arm.  he is doing fine.
Fever, chills and by morning a hot sore upper arm with a 4" x 3" welt.
After the 4th and final imm given, which was the HPV vaccine, client, who was placed on exam table and lying down during vaccine administration, her eyes rolled back and she made a deep snoring noise. Her back began to arch and her arms drew up and tightened like with seizure activity. Client was unconscious. Client had rapid pulse. After 30 sec or so, client came to and answered to her name. Cool rags were applied to her chest and forehead, she was fanned with paper RN had in her hand. A Coke was given to client once consciousness gained. After 2-3 minutes client stated she felt fine. She was observed 15-20 minutes after losing consciousness and walked out of Health Dept without assistance with her mother and 2 brothers. Mother states she has a history of passing out and having seizure like activity after vaccines or the sight of blood.
Information has been received from a physician concerning a patient who on 14-AUG-2007 was vaccinated with a dose of varicella virus vaccine live (Oka/Merck) and experienced anaphylaxis after vaccination. It was unknown whether medical attention was sought. The recovery status was unknown. This is one of several reports from the same source. Attempts are being made to obtain additional identifying information to distinguish the individual patients mentioned in this report. Additional information will be provided if available.
This spontaneous report as received from a medical assistant refers to an unspecified number of patients of unknown age and gender. On an unspecified date in 2014 (reported as "vaccinations occurred between 13-OCT-2014 and 17-NOV-2014"), an unspecified number of patients received PEDVAX HIB (doses, routes of administration, lot # and expiration dates were not reported) stored at 33F for 3 hours. No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
Pt received his second dose of Moderna at :10 am on 4-8-21.  At approx 9:15 he started to feel weak and light headed, stating he felt like he was going to pass out.  Asked if he could lay down.  Took him into the counseling room, placed him on the floor and elevated his legs. We went to get him a cold water and an ice pak for his headache.  Pt laid there for 5 more minutes then sat up and we gave him two sugar cookies.  Pt gradually stood up to sit upright in a chair. He drank another cold water and we observed him for 30 more minutes.  Approx 9:45 am Pt stated he was feeling much better and was ready to go home.  He did have a driver with him whom walked him out to the car and got him to his residence.  Upon 5:30 pm on 4-8-21 pt had not experienced anymore symptoms besides tiredness,  He was counseled to go to the ER if he experience any other unusual occurences.
Stage zero breast cancer identified on MRI on April 22, 2021.  Multiple side effects after 2nd vax and prior to date of diagnosis.  Double mastectomy June 21, 2021.  Resolved.
lethargic; sweating profusely; weak; tenderness at injection site; Injection site swelling; chills; Fever; body aches; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE SWELLING (Injection site swelling) and PYREXIA (Fever) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     No Medical History information was reported.  On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced INJECTION SITE SWELLING (Injection site swelling) and PYREXIA (Fever). On 23-Jan-2021, INJECTION SITE SWELLING (Injection site swelling) had resolved. On 24-Jan-2021, PYREXIA (Fever) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 100 (High) temperature was 100 F.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided by the reporter. No treatment information was provided.
Vaccines were administered at 1015 this am (8/14/19). Pt did well following administration. Mom called at 1525 this afternoon (8/14/19) and stated that pt was having fever (tmax 101 oral), headaches, and generalized aching. Her arms were painful to move. Verified that these are common side effects. Reviewed with mother and advised to please call with worsening or further concerns / questions. Made provider aware as well.
Diagnosed with covid-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Diagnosed with covid-19) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced COVID-19 (Diagnosed with covid-19). At the time of the report, COVID-19 (Diagnosed with covid-19) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Apr-2021, SARS-CoV-2 test: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication reported.  Treatment information not provided.
Infant given injection of 0.5 cc. of H1N1 Inactivated Flu Injection instead of 0.25 cc.
I woke up that morning and noticed that I was having pretty severe discomfort under my left arm pit. Noticed there was a huge area of swelling and tenderness. Contacted the doctor and left a message with the nurse line. When the called me back, I told them I noticed some swelling in my lymph nodes under my left arm pit. They scheduled me for an appointment with the doctor. I saw her on May 3rd. She ordered bloodwork and an ultrasound on that area. May 4th, I went in for the urgent ultrasound. May 10th I received my report back from the doctor. Bloodwork came out fine. No elevated white blood cell count. No indication of an infection. Ultrasound report read as a cluster of lymph nodes 2.4 cm. Did not indicate anything concerning. My body might've been fighting something but they don't know. They will monitor it. I go back in August for another ultrasound and imaging. Since then, the swelling has gone down. No medication administered. Just warm compresses under the arm.
Diffuse urticaria, mild bilateral finger and toe swelling that developed the day after receiving the vaccine. Seen in the ED 2 days post vaccine for persistent symptoms that did not resolve prior to discharge.
itching/head, back, arms and feet itching; Hives or rash present; This is a spontaneous report from a non-contactable other HCP (Nurse). A 74-years-old patient of an unspecified gender received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number: EW0150), via an unspecified route of administration on an unspecified date at 17:14 as dose 2, single (Age at vaccination: Unknown) for COVID-19 immunization. Patient had earlier received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution injection, Lot number/Expiration date: Unknown) on an unspecified date for covid-19 immunization. Medical history included asthma, tachycardia, hypertension, diabetes mellitus. Concomitant medications includes Vitamins. Patient Allergies (food/drugs/etc.) includes Penicillin, Acrylic allergy. Patient denies Illness at time of vaccination or up to 1-month prior. On an unspecified date the patient experienced itching/head, back, arms and feet itching and hives or rash present. The patient underwent lab tests and procedures which included BP (blood pressure measurement): 131/74, HR (heart rate): 67, O2 SAT (oxygen saturation): transmit too long, RESP (respiratory rate): 18. Therapeutic measures were taken as a result of itching/head, back, arms and feet itching, hives or rash present which includes Diphenhydramine (Dose: 25mg; Route: PO). Stated relief of itching at 17:50 (10 mins after taking PO Diphenhydramine). No CPR indicated. The outcome of event itching/head, back, arms and feet itching was recovering while outcome of event hives or rash present was unknown. No follow-up attempts are possible; no further information expected.
GIVEN VACCINE ON 11/8/2021. RETURNED TO CLINIC ON 11/10/2021 WITH LEFT SHOULDER ERYTHEMA. NOT WARM TO THE TOUCH. APROXIMATELY 1/2 INCH. PRESCRIBED BENADRYL 25MG Q12 HOURS/PRN AND MOTRIN 400MG Q12 HOURS/PRN.
Painful as serum entered body, was escorted to the observation area, sat down, within minutes my heart rate felt really high. Tight/heavy chest. Stayed the half hour plus ten extra minutes of my own accord. Guy at desk gave me some apple juice. Thought I was okay, went on some errands, got home.. extremely fatigued, heart rate at 108, light headed a bit of nausea. Heart rate stayed strong at 108 for about 8 hours after receiving shot. Had neighbor check on me hourly, called ask a nurse.. she told me to rest and drink lots of water and if my heart rate went to 120 go to the ER. Slept for a few hours. Heart rate seems normal as of today(April 1st).  Very worried about 2nd dose.
After vaccines patient had flushed pink confluent rash on face and left upper leg where vaccines were done. No hives and no difficulty breathing. Gave 2.5 ml of BENADRYL and watched patient. Rash resolved.
Pregnancy; Left arm pain at the site of injection; This spontaneous prospective pregnancy case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of EXPOSURE DURING PREGNANCY (Pregnancy) and INJECTION SITE PAIN (Left arm pain at the site of injection) in a 36-year-old female patient (gravida 2) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025A21A and 043L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on 02-Feb-2021 and the estimated date of delivery was 09-Nov-2021. On 03-Mar-2021, the patient experienced INJECTION SITE PAIN (Left arm pain at the site of injection). On 05-Mar-2021, the patient experienced EXPOSURE DURING PREGNANCY (Pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  fourth week of the pregnancy.  On 05-Mar-2021, EXPOSURE DURING PREGNANCY (Pregnancy) had resolved. At the time of the report, INJECTION SITE PAIN (Left arm pain at the site of injection) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Mar-2021, Pregnancy test: positive (Positive) Positive.         Concomitant product used was not provided by the reporter. This patient went to a nearby clinic and was told to follow-up with the hospital. Treatment information was not provided. Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) in response to the events was not applicable.
Fever above 103. Bruises at injection sight. Child appeared to be shivering, rubbing arms, looked frightened. As the parent I was frightened.
pt became cold & achy, progressed to fever of 102.5 w/chills & severe h/a;pt called ER @ hosp & was told to take APAP for h/a;pt states still has h/a & receives moderate relief w/APAP;
nose bleeds for more than 3 hours/nose bleeds were worse; This is a spontaneous report from a contactable consumer (patient). A non-pregnant female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: EN6207) via an unspecified route of administration, administered in Arm Left on 10Mar2021 12:00 AM, as dose 1, single for COVID-19 immunization. Medical history included hypertension and known allergies: Sulphur drugs from an unknown date and unknown if ongoing. There were no concomitant medications reported in two weeks. No other vaccine in four weeks. No COVID prior to the vaccination. No test for COVID post vaccination. On 12Mar2021, Starting Friday after vaccine, nose bleeds for more than 3 hours. Sunday nose bleeds were worse and lasted appx. 5 hours. No treatment was given for adverse event. The outcome of the event was unknown.  No follow-up attempts are possible. No further information is expected.
vax was given intravenously through dialysis blood tubing as an IV push med;pt had no complaints; no adverse signs/sxs;
pt recvd vax & 30-60 mins post vax pt exp flu-like sx;sx subsided;pt's personal MD thought that the sx were unrelated to the inj
BREAKTHROUGH COVID: PT FULLY VACCINATED WITH BOOSTER. admitted on June 2, 2022 with lower back pain, fevers.  Patient was septic on arrival leukocytosis, treat her sepsis, UTI, bacteremia. Pt tested positive for COVID-19 as she experienced a scratchy throat.  She did not want to tell nursing staff so she told her family who brought in a home test kit and she tested positive.  When she tested positive then the daughter relayed this information to the staff and she had a hospital test which was positive.  Patient was not hypoxic however.  She did not require any significant treatment for covid-19 infection without respiratory compromise.
11/3/00, 3-4 hours post vax, she felt weak, lethargic and had diarrhea. Admitted to the hospital on 11/4/00 with hypovolemic shock and acute gastroenteritis. Diagnosed also with possible reaction to vaccines and cachexia. Per F/U 3/28/01: DX: CHF due to arteriosclerotic coronary disease, mitral regurgitation and tricuspid insufficiency. She had dehydration and was given IV fluids and responded quite promptly with an increase in strength and mental acuity. After slow improvement over a period of 5 days, she was discharged.
Pt. had few spots on abdomen and 104 degrees after nap at 2:00pm mother called family MD  - instructed to use tylenol. Today 3/22/05 pt. stomach covered with rash and swelling noted around eyes to ears and around nose. Family MD notified mother instructed to use Benadryl. mother notified us at 9:30 on 3/22/05 to file report per MD.
c/o fever, chills, lightheadedness, and generalized body aches after receiving J&J COVID vaccine yesterday.  Pt states she is currently feeling better than last night with OTC medications.
Pt called call center reporting dizziness and weakness since 4/29/21.Feels like "passing out" Pt stated she had fever,chills,covid vaccine injection side arm pain but resolved these sx with tylenol after couple days. Pt recommended to go to ED for further Evaluation
This client was inadvertently administered a Moderna covid vaccine 1 and 2 at a mass vaccine site by a volunteer vaccinator, client is 13 years of age. Client had been referred by the shelter.
Within 5 minutes of receiving Moderna vaccine I felt disoriented. Within 10 minutes my face began to feel numb. This lasted for about 3 hours, then lifted.
tingling in fingers, arms, feet; night sweats; Numbness; other vaccine same date product Pfizer 12+; other vaccine same date product Pfizer 12+; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 56-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 26Jun2023 at 14:30 as dose 4 (booster), single (Lot number: GJ6743) at the age of 56 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "Sleep apnea" (unspecified if ongoing). Concomitant medication(s) included: FIBER; MAGNESIUM. Vaccination history included: BNT162b2 (DOSE 3 (BOOSTER), SINGLE , Lot number: FP7137), administration date: 26Jun2023, when the patient was 56-year-old, for COVID-19 immunization; Covid-19 vaccine (DOSE 2, SINGLE , Lot number and expiration date not provided.), for COVID-19 immunization; Covid-19 vaccine (DOSE 1, SINGLE , Lot number and expiration date not provided.), for COVID-19 immunization. The following information was reported: INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (non-serious), OVERDOSE (non-serious) all with onset 26Jun2023 at 14:30, outcome "unknown" and all described as "other vaccine same date product Pfizer 12+"; HYPOAESTHESIA (non-serious) with onset Jul2023, outcome "not recovered", described as "Numbness"; NIGHT SWEATS (non-serious) with onset Jul2023, outcome "not recovered"; PARAESTHESIA (non-serious) with onset Jul2023, outcome "not recovered", described as "tingling in fingers, arms, feet". The events "tingling in fingers, arms, feet", "night sweats" and "numbness" required physician office visit and emergency room visit. Therapeutic measures were not taken as a result of paraesthesia, night sweats, hypoaesthesia.  Additional Information: No allergies, no treatment, no covid prior vaccination, no covid tested post vaccination, no other vaccines in 4weeks.
Black stool; This spontaneous case was reported by a consumer and describes the occurrence of FAECES DISCOLOURED (Black stool) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M(Z/2)01) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history.).    On 29-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Jan-2021, the patient experienced FAECES DISCOLOURED (Black stool). At the time of the report, FAECES DISCOLOURED (Black stool) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.